-
基于全生命周期理念的多发性骨髓瘤患者“互联网 ”全病程管理模式的构建
讲者:江巧琳 -
第四代CAR-T治疗B细胞淋巴瘤的长期疗效和安全性
讲者:刘辉 -
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study
讲者:束金辉 -
血液肿瘤患者多种病原微生物血流感染的临床特征和死亡危险因素分析
讲者:杨武晨 -
鼻外NK/T细胞淋巴瘤患者临床特征和预后分析——淮海淋巴瘤协作组多中心回顾性研究
讲者:沈子园 -
BTK/Rap1/NF-κB通路介导巨噬细胞异常极化在脓毒症相关性血小板减少症中的作用和机制研究
讲者:张紫妍 -
Experimental study on the induction of apoptosis in acute myeloid leukemia cell line Kasumi-1 by the combination of total coumarins of Hedyotis diffusa and Akt inhibitor Perifosine
讲者:陈智 -
伊布替尼治疗慢性淋巴细胞白血病的中国真实世界研究
讲者:杨申淼 -
Optimizing Stem Cell Infusion Timing in the Prevention of Acute Graft versus Host Disease
讲者:吴月 -
依马利尤单抗联合芦可替尼治疗噬血细胞综合征
讲者:宋悦 -
STK10 mutation block erythropoiesis in acquired pure red cell aplasia via down-regulated the ribosome biosynthesis
讲者:龙章彪 -
Application of plasma metagenomic next-generation sequencing improves prognosis in hematology patients with neutropenia or hematopoietic stem cell transplantation for infection
讲者:陈玉慧